CLINICAL_TRIALS
trial_result
· 2009-11-19
Clinical Trial Update: Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST) [Phase 3]
Summary
Phase 3 randomized trial evaluating tipranavir in multidrug-resistant HIV infection; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2009-11-19